We identified two splicing variants of Slit2 at exon 15; Slit2-ΔE15 inhibited the proliferation and invasion/motility of CL1-5 lung cancer cells, while Slit2-WT solely inhibited invasion/motility activity [22]. This evidence concerns the gene SLIT2 and lung carcinoma.